Close Menu

Veracyte

The firm also disclosed that it has paid $1.2 million in severance and bonuses related to its acquisition of Allegro Diagnostics.

The firm's full-year revenues were driven by increased Afirma Gene Expression Classifier test volume and penetration into the endocrinology market.

Veracyte's study raised concerns over using NGS mutational data in diagnosing thyroid nodules, while Interpace suggested a combination approach.

Among the other gainers in the month were Vermillion, Sequenom, and GenMark, while Rosetta Genomics, NanoString, and Foundation Medicine saw their shares fall. 

Under the terms of the agreement, Veracyte can borrow up to $15 million in three tranches of up to $5 million each.

San Francisco-based Veracyte today announced that Blue Shield of California has issued a positive coverage policy for the firm's Afirma Gene Expression Classifier.

Veracyte reported after the close of the market on Thursday a 75 percent jump in revenues for the third quarter.

Vanderbilt University has appointed Nancy Cox the founding director of the new Vanderbilt Genetics Institute, effective Jan. 1, 2015. She also will be a professor of genetics and direct the division of genetic medicine in the department of medicine.

NEW YORK (GenomeWeb) – Shares of firms operating in the molecular diagnostics and omics spaces reversed losses suffered in September as the GenomeWeb Daily News Index rose nearly 8 percent month over month in October.

NEW YORK (GenomeWeb) – New thyroid cancer mutations reported recently by members of The Cancer Genome Atlas consortium are already finding their way into at least one sequencing-based genotyping test used to distinguish between benign thyroid nodules and thyroid malignancies.

Pages

The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.